Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07219810 · ClinicalTrials.gov registry record · NA
Accelerated iTBS Targeting of Working Memory Versus Inhibitory Control in Adolescent ADHD
A NA study of ADHD, sponsored by Bradley Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07219810: Recruiting NA study of ADHD, sponsored by Bradley Hospital.
NCT07219810 is a NA study of ADHD that is actively recruiting participants, run by Bradley Hospital. The registered enrollment target is 50 participants, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07219810, a NA study of ADHD, is actively recruiting participants, sponsored by Bradley Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this project is to examine the differential therapeutic effect of intermittent theta burst stimulation (iTBS; a type of repetitive transcranial magnetic stimulation) to the left DLPFC versus right PreSMA in modulating working memory (WM) versus inhibitory control (IC) deficits. Fifty adolescents (12-18 years old) with parent-reported WM and IC deficits and diagnosed ADHD will be randomized to DLPFC or PreSMA targeted 3x-daily iTBS for a total of ten days (30 total sessions).
Primary Outcome
PreSMA-targeted iTBS will lead to greater relative activation of the IC network versus the WM network (and the opposite pattern for DLPFC-targeted iTBS).
Conditions Studied
Interventions
- DEVICE intermittent theta burst stimulation (iTBS)
Study Locations (1)
Rhode Island
- E. P. Bradley Hospital - East Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-09-01 |
| Est. Completion | 2029-09-01 |
| Phase | NA |
What NCT07219810 shows while recruiting
NCT07219810 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (74% lower).
The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 1 intervention - of which intermittent theta burst stimulation (iTBS) is the first listed.
NCT07219810 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT07219810 about?
NCT07219810 is a clinical study titled "Accelerated iTBS Targeting of Working Memory Versus Inhibitory Control in Adolescent ADHD". The objective of this project is to examine the differential therapeutic effect of intermittent theta burst stimulation (iTBS; a type of repetitive transcranial magnetic stimulation) to the left DLPFC versus right PreSMA in modulating working memory (WM) versus inhibitory control (IC) deficits. Fift...
What is the current status of trial NCT07219810?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-09-01. Estimated completion is 2029-09-01.
What conditions does trial NCT07219810 study?
This clinical trial studies the following conditions: ADHD.
What interventions are being tested in trial NCT07219810?
The interventions under investigation include: intermittent theta burst stimulation (iTBS) (DEVICE).
Who is sponsoring clinical trial NCT07219810?
This trial is sponsored by Bradley Hospital, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07219810 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ADHD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07219810's enrollment target sits among peer trials
50 45th of 75 higher than 28 of 75 other ADHD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other ADHD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Target ADHD Executive Working Memory Replication Study
RECRUITING · NA
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Fidgeting and Attentional and Emotional Regulation in ADHD
RECRUITING · NA
-
Moms Managing Attention-Deficit/Hyperactivity Disorder (ADHD) Study
RECRUITING · NA
-
A Pilot Study of a Remote ADHD Monitoring Program
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI